PFKFB3: A Potential Key to Ocular Angiogenesis
The current treatment for ocular pathological angiogenesis mainly focuses on anti-VEGF signals. This treatment has been confirmed as effective despite the unfavorable side effects and unsatisfactory efficiency. Recently, endothelial cell metabolism, especially glycolysis, has been attracting attenti...
Main Authors: | Zi-Yi Zhou, Lin Wang, Yu-Sheng Wang, Guo-Rui Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.628317/full |
Similar Items
-
The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
by: Besa Emini Veseli, et al.
Published: (2021-05-01) -
MALAT1 sponges miR-26a and miR-26b to regulate endothelial cell angiogenesis via PFKFB3-driven glycolysis in early-onset preeclampsia
by: Qi Li, et al.
Published: (2021-03-01) -
Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia
by: Jiean Xu, et al.
Published: (2021-09-01) -
HSF1 promotes endometriosis development and glycolysis by up-regulating PFKFB3 expression
by: Yixin Wang, et al.
Published: (2021-06-01) -
Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3)
by: D. A. Richardson, et al.
Published: (2020-04-01)